Juno Therapeutics pays $59M for Stage Cell Therapeutics, continues to burn cash in search of cancer treatment by Blair Hanley Frank on May 11, 2015May 11, 2015 at 2:20 pm Juno Therapeutics has paid $59 million to acquire Stage Cell Therapeutics, a privately held biotech company based in Germany. Stage Cell, which is privately held, is known for its cell… Read More